Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mario Visconti"'
Autor:
Tiziana Ciarambino, Alfonso Ilardi, Orazio Valerio Giannico, Ada Maffettone, Filippina Ciaburri, Venere Delli Paoli, Andrea Fontanella, Paolo Tirelli, Carolina Bologna, Fernando Gallucci, Mario Visconti, Domenico Caruso, Maria Amitrano, Mauro Giordano, Maria D'Avino
Publikováno v:
Italian Journal of Medicine, Vol 15, Iss 3 (2021)
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has infected millions of individuals around the World. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM), particularly in the elderly, increase susceptibili
Externí odkaz:
https://doaj.org/article/daee20baa1e0479189501067e19b9ced
Autor:
Mario Visconti
Publikováno v:
Italian Journal of Medicine, Vol 9, Iss 3, Pp 217-228 (2015)
Proton pump inhibitors (PPIs) are the most potent drugs for reducing gastric acid secretion; so, since their release in the late 1980s, they have been recommended as the first therapeutic choice for many gastroesophageal diseases, risk reduction in o
Externí odkaz:
https://doaj.org/article/0dd91f549c694e8993b6635b60eef4e5
Autor:
Mario Visconti
Publikováno v:
Italian Journal of Medicine, Vol 9, Iss 1, Pp 20-36 (2015)
Autoimmune liver diseases are disorders of unknown etiology and immune pathogenesis, characterized by liver parenchyma inflammation (autoimmune hepatitis) or by lesions of the intralobular biliary ducts (primary biliary cirrhosis) or of the entire bi
Externí odkaz:
https://doaj.org/article/110415959b11454580488b812ef39fef
Publikováno v:
Italian Journal of Medicine, Vol 5, Iss 4, Pp 278-281 (2012)
Introduction: Loss of HBsAg is observed in only 3-4% of patients who receive interferon for chronic HBV+HCV hepatitis, and there are few reports of HBsAg loss induced by treatments other than interferon. We report a case of chronic HBV+HCV hepatitis,
Externí odkaz:
https://doaj.org/article/824b345be0ef41c0b11d024e353d1ab9
Autor:
Simona Signoriello, Annalisa Annunziata, Nicola Lama, Giuseppe Signoriello, Paolo Chiodini, Ilario De Sio, Bruno Daniele, Giovanni G. Di Costanzo, Fulvio Calise, Graziano Olivieri, Vincenzo Castaldo, Rosario Lanzetta, Guido Piai, Giampiero Marone, Mario Visconti, Mario Fusco, Massimo Di Maio, Francesco Perrone, Ciro Gallo, Giovanni B. Gaeta
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Evidence of relative effectiveness of local treatments for hepatocellular carcinoma (HCC) is scanty. We investigated, in a retrospective cohort study, whether surgical resection, radiofrequency ablation (RFA), percutaneous ethanol injection (PEI), an
Externí odkaz:
https://doaj.org/article/d3a2e6e4ec4d4aae813574e88adeed08
Publikováno v:
Italian Journal of Medicine, Vol 5, Iss 4, Pp 278-281 (2012)
Introduction: Loss of HBsAg is observed in only 3-4% of patients who receive interferon for chronic HBV+HCV hepatitis, and there are few reports of HBsAg loss induced by treatments other than interferon. We report a case of chronic HBV+HCV hepatitis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54d5d783d5bfc23db477547c3c44bca
https://doi.org/10.1016/j.itjm.2011.07.013
https://doi.org/10.1016/j.itjm.2011.07.013
Autor:
Carolina Di Somma, Mario Visconti, Caterina Scelzi, Antonio Salvio, Stefano Spiezia, Francesco Giannattasio, Maria Varriale, A. P. Assanti
Publikováno v:
European Journal of Ultrasound. 15:127-131
Objective: To evaluate the safety and compliance of outpatient echo-guided liver biopsy (ELB) when compared to those performed on inpatients (IP). Methods: From June 1996 to November 2000, we carried out 418 ELB on patients with diffuse liver disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934ba086d5fe414cc55cd3778ea361b8
https://doi.org/10.1016/s0929-8266(02)00033-2
https://doi.org/10.1016/s0929-8266(02)00033-2
Autor:
Paolo Chiodini, Francesco Perrone, Mario Fusco, Nicola Lama, Vincenzo Castaldo, F. Calise, Massimo Di Maio, Ilario de Sio, Graziano Olivieri, Ciro Gallo, Bruno Daniele, Giovanni Battista Gaeta, Giovanni G. Di Costanzo, Guido Piai, Giuseppe Signoriello, Simona Signoriello, Giampiero Marone, Mario Visconti, Rosario Lanzetta, Annalisa Annunziata
Publikováno v:
The Scientific World Journal
The Scientific World Journal, Vol 2012 (2012)
The Scientific World Journal, Vol 2012 (2012)
Evidence of relative effectiveness of local treatments for hepatocellular carcinoma (HCC) is scanty. We investigated, in a retrospective cohort study, whether surgical resection, radiofrequency ablation (RFA), percutaneous ethanol injection (PEI), an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc49f8005778db9251d35a85951e7819
http://europepmc.org/articles/PMC3356712
http://europepmc.org/articles/PMC3356712